{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:11:34Z","timestamp":1790737894031,"version":"4.1.0"},"reference-count":34,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol Psychiatr Sci"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:p>Cannabidiol (CBD) represents a new promising drug due to a wide spectrum of pharmacological actions. In order to relate CBD clinical efficacy to its pharmacological mechanisms of action, we performed a bibliographic search on PUBMED about all clinical studies investigating the use of CBD as a treatment of psychiatric symptoms. Findings to date suggest that (a) CBD may exert antipsychotic effects in schizophrenia mainly through facilitation of endocannabinoid signalling and cannabinoid receptor type 1 antagonism; (b) CBD administration may exhibit acute anxiolytic effects in patients with generalised social anxiety disorder through modification of cerebral blood flow in specific brain sites and serotonin 1A receptor agonism; (c) CBD may reduce withdrawal symptoms and cannabis\/tobacco dependence through modulation of endocannabinoid, serotoninergic and glutamatergic systems; (d) the preclinical pro-cognitive effects of CBD still lack significant results in psychiatric disorders. In conclusion, current evidences suggest that CBD has the ability to reduce psychotic, anxiety and withdrawal symptoms by means of several hypothesised pharmacological properties. However, further studies should include larger randomised controlled samples and investigate the impact of CBD on biological measures in order to correlate CBD's clinical effects to potential modifications of neurotransmitters signalling and structural and functional cerebral changes.<\/jats:p>","DOI":"10.1017\/s2045796018000239","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T04:54:09Z","timestamp":1527051249000},"page":"327-335","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":74,"title":["Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview"],"prefix":"10.1017","volume":"27","author":[{"given":"G. M.","family":"Mandolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lazzaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pigoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Oldani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Delvecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"S2045796018000239_ref33","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108096519"},{"key":"S2045796018000239_ref29","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X14666160509123955"},{"key":"S2045796018000239_ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-005-6978-1"},{"key":"S2045796018000239_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2016.11.012"},{"key":"S2045796018000239_ref18","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.17030325"},{"key":"S2045796018000239_ref14","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13724"},{"key":"S2045796018000239_ref12","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-44462010000100011"},{"key":"S2045796018000239_ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e32803dbdec"},{"key":"S2045796018000239_ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110379283"},{"key":"S2045796018000239_ref4","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2011.0389"},{"key":"S2045796018000239_ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.01176.x"},{"key":"S2045796018000239_ref34","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108096521"},{"key":"S2045796018000239_ref3","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S109576"},{"key":"S2045796018000239_ref2","first-page":"46","article-title":"The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial","volume":"44","author":"Boggs","year":"2018","journal-title":"Schizophrenia Bulletin"},{"key":"S2045796018000239_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2016.06.022"},{"key":"S2045796018000239_ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00020"},{"key":"S2045796018000239_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12018"},{"key":"S2045796018000239_ref22","doi-asserted-by":"publisher","DOI":"10.14581\/jer.17012"},{"key":"S2045796018000239_ref28","first-page":"31","article-title":"Cannabidiol oil for decreasing addictive use of marijuana: a case report","volume":"14","author":"Shannon","year":"2015","journal-title":"Integrative Medicine (Encinitas)"},{"key":"S2045796018000239_ref24","first-page":"33","article-title":"Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence","volume":"9","author":"Prud'Homme","year":"2015","journal-title":"Substance Abuse: Research and Treatment"},{"key":"S2045796018000239_ref11","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbx105"},{"key":"S2045796018000239_ref1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.6"},{"key":"S2045796018000239_ref25","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10095"},{"key":"S2045796018000239_ref13","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13250"},{"key":"S2045796018000239_ref9","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1780"},{"key":"S2045796018000239_ref31","first-page":"485","article-title":"Antipsychotic effect of cannabidiol [3]","volume":"56","author":"Zuardi","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"key":"S2045796018000239_ref27","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.195"},{"key":"S2045796018000239_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.02.041"},{"key":"S2045796018000239_ref32","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106060967"},{"key":"S2045796018000239_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2013.03.011"},{"key":"S2045796018000239_ref15","first-page":"S341","article-title":"The endocannabinoid system in schizophrenia-a mechanistically new approach to its pathophysiology and treatment","volume":"39","author":"Leweke","year":"2013","journal-title":"Schizophrenia Bulletin"},{"key":"S2045796018000239_ref16","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.15"},{"key":"S2045796018000239_ref7","doi-asserted-by":"publisher","DOI":"10.2174\/1871527313666140612114838"},{"key":"S2045796018000239_ref17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ejp.1148","article-title":"Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings","volume":"22","author":"L\u00f6tsch","year":"2018","journal-title":"European Journal of Pain (United Kingdom)"}],"container-title":["Epidemiology and Psychiatric Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2045796018000239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T08:47:31Z","timestamp":1604306851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2045796018000239\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S2045796018000239"],"URL":"https:\/\/doi.org\/10.1017\/s2045796018000239","relation":{},"ISSN":["2045-7960","2045-7979"],"issn-type":[{"value":"2045-7960","type":"print"},{"value":"2045-7979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2018\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}